KMDA - Latest News

Kamada Ltd. (KMDA), operates in Healthcare / Drug Manufacturers - Specialty & Generic, trades on NASDAQ.

Market capitalization stands near $443.7M. Trailing twelve-month P/E ratio is 20.01. Beta to the broader market is 0.14.

The article list below shows the most recent KMDA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent KMDA Headlines

Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel

globenewswire.com - Oct 6, 2026

Company Expects Growing Biosimilar Product Portfolio, Commercialized in Israel and the MENA Region, to Generate Approximately $10 Million in Annual Re

Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth

defenseworld.net - Sep 28, 2026

Kamada (NASDAQ: KMDA) outlined its growth strategy, product portfolio and financial outlook during a company presentation, emphasizing demand for spec

Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth

marketbeat.com - Sep 27, 2026

Kamada NASDAQ: KMDA outlined its growth strategy, product portfolio and financial outlook during a company presentation, emphasizing demand for specia

CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

globenewswire.com - Sep 17, 2026

U. S.

Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

globenewswire.com - Sep 10, 2026

REHOVOT, Israel, and HOBOKEN, N. J.

How News Affects KMDA Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track KMDA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked KMDA news questions

What is the latest KMDA news headline?

The most recent KMDA headline (Oct 6, 2026) is "Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the KMDA news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What KMDA news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual KMDA options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.